Search JTA's historical archive dating back to 1923

News Brief

June 8, 2006
See Original Daily Bulletin From This Date

The American Food and Drug Administration recently approved a drug developed in Israel to treat Parkinson’s disease. Azilect, which is now available to patients, is the first Parkinson’s medication with once-daily dosage. Professors at the Technion-Israel Institute of Technology in Haifa worked alongside Israeli pharmaceutical company Teva to develop the drug.

Recommended from JTA